Cargando…

Prognostic Values of Fluctuations in Serum Levels of Alanine Transaminase in Inactive Carrier State of HBV Infection

BACKGROUND: Current guidelines introduce periodic monitoring of serum alanine transaminase (ALT) as the first-line modality in follow-up patients, with a hepatitis B virus (HBV) inactive carrier state. OBJECTIVES: This study aimed to determine the incidence rate and patterns of ALT fluctuations and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farzi, Hossein, Ebrahimi Daryani, Nasser, Mehrnoush, Leila, Salimi, Shima, Alavian, Seyed Moayed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013498/ https://www.ncbi.nlm.nih.gov/pubmed/24829590 http://dx.doi.org/10.5812/hepatmon.17537

Ejemplares similares

Erratum to: Prognostic Values of Fluctuations in Serum Levels of Alanine Transaminase in Inactive Carrier State of HBV Infection [Published in Hepatitis Monthly. 2014 May; 14(5): e17537]
Publicado: (2014)

Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings
por: Khosravi, Somaye, et al.
Publicado: (2011)

Liver Hemangioma Might Lead to overestimation of Liver Fibrosis by Fibroscan; A Missed Issue in Two Cases
por: Aalaei-Andabili, Seyed Hossein, et al.
Publicado: (2012)

Impact of the IL-10 Promoter Gene Polymorphisms in the Severity of Chronic Hepatitis B Infection
por: Ghaleh Baghi, Sahand, et al.
Publicado: (2015)

Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
por: Pouresmaeeli, Mahdiyar, et al.
Publicado: (2015)

Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013
por: Ebrahimi Daryani, Nasser, et al.
Publicado: (2013)

Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, November 2011, Tehran, Iran
por: Alavian, Seyed Moayed, et al.
Publicado: (2012)

Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response
por: Sharafi, Heidar, et al.
Publicado: (2012)

Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals
por: Sharafi, Heidar, et al.
Publicado: (2012)

Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
por: Sandoughdaran, Saleh, et al.
Publicado: (2015)

Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence
por: Ghanaati, Hossein, et al.
Publicado: (2012)

Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up
por: Sali, Shahnaz, et al.
Publicado: (2013)

The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C
por: Behnava, Bita, et al.
Publicado: (2016)

The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C
por: Kadjbaf, Danesh, et al.
Publicado: (2016)

Management of Liver Hemangioma Using Trans-Catheter Arterial Embolization
por: Firouznia, Kavous, et al.
Publicado: (2014)

A Rise in Aspartate Transaminase and Alanine Transaminase Associated With Ondansetron Administration in a Pregnant Female
por: Couse, Michael, et al.
Publicado: (2020)

Inactive Hepatitis B Carrier and Pregnancy Outcomes: A Systematic Review and Meta–analysis
por: KERAMAT, Afsaneh, et al.
Publicado: (2017)

Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis
por: Aalaei-Andabili, Seyed Hossein, et al.
Publicado: (2014)

Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

Gender Differences in Healthy Ranges for Serum Alanine Aminotransferase Levels in Adolescence
por: Poustchi, Hossein, et al.
Publicado: (2011)

Idiopathic portal hypertension in an "inactive" HBV carrier: a case report
por: Vassiliadis, Themistoklis G, et al.
Publicado: (2008)

Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy
por: Mo, Qiuyan, et al.
Publicado: (2022)

Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients
por: Wu, Jiayuan, et al.
Publicado: (2019)

The association of aspartate transaminase-to-alanine transaminase ratio and metabolic syndrome among HIV patients in Sidama Region, South Ethiopia
por: Abera, Wondwossen, et al.
Publicado: (2023)

Occult Hepatitis B Virus Among the Patients With Abnormal Alanine Transaminase
por: Makvandi, Manoochehr, et al.
Publicado: (2014)

Evolutionary Diversification of Alanine Transaminases in Yeast: Catabolic Specialization and Biosynthetic Redundancy
por: Escalera-Fanjul, Ximena, et al.
Publicado: (2017)

The Effect of Elevated Alanine Transaminase on Non-invasive Prenatal Screening Failures
por: Chen, Ping, et al.
Publicado: (2022)

How Can We Make Decision for Patients With Chronic Hepatitis B According to Hepatitis B Virus (HBV) DNA Level?
por: Keshvari, Maryam, et al.
Publicado: (2014)

The Association between Fruit and Vegetable Intake and Liver Enzymes (Aspartate and Alanine Transaminases) in Tehran, Iran
por: Mollahosseini, Mehdi, et al.
Publicado: (2017)

Alanine Represses γ-Aminobutyric Acid Utilization and Induces Alanine Transaminase Required for Mitochondrial Function in Saccharomyces cerevisiae
por: Márquez, Dariel, et al.
Publicado: (2021)

Plasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?
por: Abbasinazari, Mohammad, et al.
Publicado: (2013)

HBV Subgenotypes D1, D2, D-del! Are ‘Old‘ Genotyping Methods Interpreted Correctly?
por: Amini-Bavil-Olyaee, Samad, et al.
Publicado: (2013)

Tenofovir alafenamide fumarate therapy in subjects with positive HBV-DNA and normal levels of alanine transaminase: a study protocol for a randomised controlled trial
por: Wang, Lu, et al.
Publicado: (2021)

The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers
por: Kim, Eun Sun, et al.
Publicado: (2011)

Multiple drugs: Elevated alanine transaminase and off label use: case report
Publicado: (2020)

Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers
por: Ijaz, Bushra, et al.
Publicado: (2011)

Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy
por: Delle Monache, Marco, et al.
Publicado: (2021)

Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis
por: Su, Shiqiang, et al.
Publicado: (2020)

Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment
por: Kang, Minyong, et al.
Publicado: (2020)

A novel diagnostic algorithm to predict significant liver inflammation in chronic hepatitis B virus infection patients with detectable HBV DNA and persistently normal alanine transaminase
por: Li, Qiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_30p2g8ccho28mhft7u89eqq5ld